Abdulmunaim Eid
Neurology · Saint Louis, MONPI 1346739638
Payments from drug & device makers
Across 200 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$527
- CSL Behring$475
- Johnson & Johnson$362
- Neurocrine Biosciences, Inc.$360
- Genentech USA, Inc.$327
- Amgen$296
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$431%
- Food & beverage$3,65199%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 29 | $527 |
| CSL Behring | 22 | $475 |
| Johnson & Johnson | 20 | $362 |
| Neurocrine Biosciences, Inc. | 18 | $360 |
| Genentech USA, Inc. | 19 | $327 |
| Amgen | 16 | $296 |
| AstraZeneca(2 entities) | 16 | $256 |
| Eisai Inc. | 14 | $232 |
| Sanofi-aventis U.S. LLC | 6 | $125 |
| Biogen | 5 | $78 |
| AbbVie(2 entities) | 4 | $73 |
| Novartis | 3 | $67 |
| Akcea Therapeutics, Inc. | 3 | $63 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $61 |
| Saol Therapeutics Inc. | 4 | $61 |
| Avanir Pharmaceuticals, Inc. | 3 | $52 |
| Acorda Therapeutics, Inc | 2 | $43 |
| Tanabe Pharma America, Inc. | 3 | $42 |
| Argenx US, Inc. | 1 | $33 |
| GRT US Holding, Inc. | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Pfizer | 2 | $26 |
| Catalyst Pharmaceuticals, Inc. | 2 | $26 |
| Shire North American Group Inc | 1 | $21 |
| Merz North America, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
How this compares
$3,694 in reported general payments places this provider in the 60th percentile of 381 neurology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $560 |
Paid to pharmacies, not to this prescriber.
Other neurology in Saint Louis
- Randall BatemanSaint Louis$92.3M
- David HoltzmanSaint Louis$25.2M
- Robert NaismithSaint Louis$13.8M
- Eric McDadeSaint Louis$9.6M
- Robert BucelliSaint Louis$8.5M
- Barbara SniderSaint Louis$7M
- Gregory WuSaint Louis$5.7M
- Barry SingerSaint Louis$3.3M
- Mark TullmanSaint Louis$2.3M
- Suzanne SchindlerSaint Louis$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.